Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
RNA Sequencing Uncovers New Subtypes of B-cell Precursor Leukaemia
March 2025
A recent study has demonstrated how RNA sequencing can enhance the genetic classification of B-cell precursor acute lymphoblastic leukaemia patients…
Read more
11 Feb 2025
Increased Cancer Risk After Cerebral Venous Thrombosis
CVT patients face a significantly higher cancer risk, especially in the first year and up to 10 years after diagnosis.
9 Feb 2025
Increased Risk of Skin Cancer After Blood or Marrow Transplant
BMT survivors face a higher risk of skin cancer, with age, graft-vs-host disease, and treatment influencing outcomes.
7 Feb 2025
Immune Checkpoint Inhibitor Before Allogeneic Transplant Boosts Survival in Hodgkin Lymphoma
ICI treatment before transplant enhances survival in relapsed Hodgkin lymphoma, though it increases the risk of acute GVHD.
5 Feb 2025
Detectable Antibodies Lower COVID-19 Risk in Immunosuppressed
Detectable antibodies reduce COVID-19 risk in immunosuppressed individuals, emphasizing the need for tailored protection strategies.
5 Feb 2025
Gene-Editing Therapy for Sickle Cell Disease Approved by NHS
The NHS has approved exa-cel, a revolutionary gene-editing therapy for sickle cell disease, offering hope for a cure.
3 Feb 2025
Shared Care Model for Hematopoietic Cell Transplantation Shows Promise
Shared care after HCT improves quality of life at day 100 without affecting survival, offering a viable post-transplant model.
1 Feb 2025
Key Metabolic Vulnerability in Multiple Myeloma Treatment
New research identifies VLCFA metabolism as a target to boost multiple myeloma treatment efficacy and combat drug resistance.
30 Jan 2025
Molecular Dynamics Behind Different Tumour Rejection Kinetics in CAR-T Cell Therapy
A recent study has uncovered key insights into the differing tumour rejection behaviours of chimeric antigen receptor T cells (CAR-T) targeting CD19…
Loading posts...
« Previous
1
2
3
4
5
6
…
32
Next »